GeneOne Life Science, Inc.
KRX:011000.KS
2,560 (KRW) • At close September 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | GeneOne Life Science, Inc. |
Symbool | 011000.KS |
Munteenheid | KRW |
Prijs | 2,595 |
Beurswaarde | 207,157,645,920 |
Dividendpercentage | 0% |
52-weken bereik | 1,996 - 4,735 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Young-Keun Park J.D., M.B.A. |
Website | https://www.genels.com |
An error occurred while fetching data.
Over GeneOne Life Science, Inc.
GeneOne Life Science, Inc., a biopharmaceutical company, engages in the development and contract manufacturing of gene-based-biomedicines. Its products comprise GLS-1027, which is in Phase I clinical trial for treatment of nephropathy and inflammatory diseases; GLS-1200 that is in Phase II clinical trial to treat Rhinosinusitis; GLS-1027 and GLS-1200, which is
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)